GlucoTrack (GCTK)
(Delayed Data from NSDQ)
$2.32 USD
+0.25 (12.15%)
Updated May 31, 2024 03:58 PM ET
After-Market: $2.32 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for GlucoTrack, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 7 | 4 | 4 | 3 | 4 |
Income After Depreciation & Amortization | -7 | -4 | -4 | -3 | -4 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -7 | -4 | -4 | -3 | -4 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -7 | -4 | -4 | -3 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -7 | -4 | -4 | -3 | -4 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -7 | -4 | -4 | -3 | -3 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -7 | -4 | -4 | -3 | -4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 4.15 | 3.10 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.90 | -1.45 | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.90 | -1.45 | -1.30 | -1.30 | -1.30 |
Fiscal Year end for GlucoTrack, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 2.95 | 2.42 | 2.22 | 1.18 | 1.28 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.95 | -2.42 | -2.22 | -1.18 | -1.28 |
Non-Operating Income | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.93 | -2.41 | -2.22 | -1.18 | -1.29 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.93 | -2.41 | -2.22 | -1.18 | -1.29 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.93 | -2.41 | -2.22 | -1.18 | -1.29 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 4.99 | 4.15 | 4.59 | 4.31 | 3.10 |
Diluted EPS Before Non-Recurring Items | -0.60 | -0.50 | -0.50 | -0.45 | -0.40 |
Diluted Net EPS (GAAP) | -0.60 | -0.55 | -0.50 | -0.45 | -0.40 |